Both, miR-129 and miR-194, were upregulated in the DCO group and should suppress FGF2 and VEGFA, subsequently reducing alveolar fibrosis and edema in ARDS. The gene discussed is VEGFA; the disease is Leri-Weill dyschondrosteosis.